Autologous bone marrow-derived mesenchymal stem cells (D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology)

N/A

Report date: 2023/01/12 15:31:42

Base Information

Drug NameAutologous bone marrow-derived mesenchymal stem cells (D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsInfertility, FemaleGynatresia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesD O Ott Research Institute Of Obstetrics And Gynecology
China Registration ClassN/A

Develop Information

Active CompaniesD O Ott Research Institute Of Obstetrics And Gynecology
Inactive CompaniesD.O. Ott Research Institute Of Obstetrics, Gynecology, And Reproductology
Active IndicationsInfertility, Female
Inactive IndicationsGynatresia

Other Information

ATC CodeN/A
Related LinksN/A